Aduro Biotech Inc (ADRO)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2023-08-01 | 2023-08-01 | V Vente |
Chief Scientific Officer Dirigeant |
1 168
-5.7%
39,0345 586 USD |
1 168 -5.7% | 39,03 | 45 586 USD | |
| 2023-05-31 | 2023-05-30 | VP Vente planifiée | Administrateur non-exécutif |
1 155
-4.7%
23,3026 912 USD |
1 155 -4.7% | 23,30 | 26 912 USD | |
| 2023-04-26 | 2023-04-24 | VP Vente planifiée |
President, CEO Administrateur exécutif |
23 800
-7.3%
21,58513 528 USD |
23 800 -7.3% | 21,58 | 513 528 USD | |
| 2023-04-19 | 2023-04-17 | V Vente | Administrateur non-exécutif |
295 808
-40.0%
20,756 138 223 USD |
295 808 -40.0% | 20,75 | 6 138 223 USD | |
| 2023-04-04 | 2023-04-04 | VP Vente planifiée | Administrateur non-exécutif |
924
-42.0%
23,0121 261 USD |
924 -42.0% | 23,01 | 21 261 USD | |
| 2023-04-05 | 2023-04-03 | VP Vente planifiée |
Chief Scientific Officer Dirigeant |
5 000
-22.7%
23,34116 718 USD |
5 000 -22.7% | 23,34 | 116 718 USD | |
| 2023-03-03 | 2023-03-01 | V Vente | Administrateur non-exécutif |
36 751
-14.8%
22,75836 085 USD |
36 751 -14.8% | 22,75 | 836 085 USD | |
| 2023-03-03 | 2023-03-01 | V Vente | Administrateur non-exécutif |
123 249
-14.6%
22,752 803 915 USD |
123 249 -14.6% | 22,75 | 2 803 915 USD | |
| 2023-03-03 | 2023-03-01 | V Vente | Administrateur non-exécutif |
240 000
-10.2%
22,755 460 000 USD |
240 000 -10.2% | 22,75 | 5 460 000 USD | |
| 2023-02-15 | 2023-02-10 | V Vente |
Chief Scientific Officer Dirigeant |
2 392
-10.9%
23,7556 806 USD |
2 392 -10.9% | 23,75 | 56 806 USD | |
| 2023-02-15 | 2023-02-10 | V Vente |
Chief Financial Officer Dirigeant |
857
-2.2%
23,7520 352 USD |
857 -2.2% | 23,75 | 20 352 USD | |
| 2023-02-15 | 2023-02-10 | V Vente |
Chief Operating Officer Dirigeant |
3 700
-2.4%
23,7587 869 USD |
3 700 -2.4% | 23,75 | 87 869 USD | |
| 2023-02-15 | 2023-02-10 | V Vente |
President, CEO Administrateur exécutif |
8 097
-2.6%
23,75192 292 USD |
8 097 -2.6% | 23,75 | 192 292 USD | |
| 2023-02-02 | 2023-01-31 | V Vente |
Chief Scientific Officer Dirigeant |
3 244
-17.7%
24,6880 069 USD |
3 244 -17.7% | 24,68 | 80 069 USD | |
| 2023-02-02 | 2023-01-31 | V Vente |
Chief Operating Officer Dirigeant |
4 566
-3.0%
24,68112 700 USD |
4 566 -3.0% | 24,68 | 112 700 USD | |
| 2023-02-02 | 2023-01-31 | V Vente |
Chief Financial Officer Dirigeant |
2 891
-7.2%
24,6871 357 USD |
2 891 -7.2% | 24,68 | 71 357 USD | |
| 2023-02-01 | 2023-01-31 | V Vente |
President, CEO Administrateur exécutif |
7 688
-2.6%
24,68189 757 USD |
7 688 -2.6% | 24,68 | 189 757 USD | |
| 2023-02-01 | 2023-01-30 | VP Vente planifiée |
President, CEO Administrateur exécutif |
25 000
-8.4%
24,54613 613 USD |
25 000 -8.4% | 24,54 | 613 613 USD | |
| 2023-01-04 | 2023-01-03 | VP Vente planifiée |
Chief Scientific Officer Dirigeant |
10 000
-50.0%
25,82258 183 USD |
10 000 -50.0% | 25,82 | 258 183 USD | |
| 2022-12-15 | 2022-12-13 | VP Vente planifiée |
Chief Operating Officer Dirigeant |
10 000
-6.5%
25,00250 005 USD |
10 000 -6.5% | 25,00 | 250 005 USD | |
| 2022-12-02 | 2022-12-01 | VP Vente planifiée |
President, CEO Administrateur exécutif |
30 000
-11.0%
22,31669 351 USD |
30 000 -11.0% | 22,31 | 669 351 USD | |
| 2022-12-02 | 2022-12-01 | V Vente |
Chief Financial Officer Dirigeant |
5 770
-14.9%
22,29128 602 USD |
5 770 -14.9% | 22,29 | 128 602 USD | |
| 2022-11-09 | 2022-11-07 | VP Vente planifiée |
Chief Operating Officer Dirigeant |
10 000
-6.5%
22,16221 642 USD |
10 000 -6.5% | 22,16 | 221 642 USD | |
| 2022-10-11 | 2022-10-06 | V Vente |
Chief Operating Officer Dirigeant |
7 360
-4.9%
19,69144 933 USD |
7 360 -4.9% | 19,69 | 144 933 USD | |
| 2022-10-11 | 2022-10-06 | V Vente |
Chief Scientific Officer Dirigeant |
3 557
-22.2%
19,6970 044 USD |
3 557 -22.2% | 19,69 | 70 044 USD | |
| 2022-09-06 | 2022-09-02 | A Achat | Administrateur non-exécutif |
300
+3.1%
21,206 360 USD |
300 +3.1% | 21,20 | 6 360 USD | |
| 2022-09-06 | 2022-09-02 | A Achat | Administrateur non-exécutif |
9 700
+inf%
21,22205 834 USD |
9 700 +inf% | 21,22 | 205 834 USD | |
| 2022-08-05 | 2022-08-04 | VP Vente planifiée |
Chief Scientific Officer Dirigeant |
5 000
-45.9%
20,00100 000 USD |
5 000 -45.9% | 20,00 | 100 000 USD | |
| 2022-07-13 | 2022-07-11 | VP Vente planifiée |
Chief Scientific Officer Dirigeant |
5 000
-45.9%
18,0990 468 USD |
5 000 -45.9% | 18,09 | 90 468 USD | |
| 2022-06-01 | 2022-05-27 | A Achat | Administrateur non-exécutif |
570 000
+12.4%
14,007 980 000 USD |
570 000 +12.4% | 14,00 | 7 980 000 USD | |
| 2022-05-27 | 2022-05-25 | A Achat |
President, CEO Administrateur exécutif |
5 000
+2.5%
13,0365 148 USD |
5 000 +2.5% | 13,03 | 65 148 USD | |
| 2022-04-13 | 2022-04-11 | VP Vente planifiée |
Chief Scientific Officer Dirigeant |
5 000
-45.9%
15,3676 812 USD |
5 000 -45.9% | 15,36 | 76 812 USD | |
| 2022-02-23 | 2022-02-18 | VP Vente planifiée |
Chief Scientific Officer Dirigeant |
2 500
-29.8%
13,0032 500 USD |
2 500 -29.8% | 13,00 | 32 500 USD | |
| 2022-02-14 | 2022-02-11 | V Vente |
Chief Financial Officer Dirigeant |
895
-3.9%
12,7411 403 USD |
895 -3.9% | 12,74 | 11 403 USD | |
| 2022-02-14 | 2022-02-11 | V Vente |
Chief Medical Officer Dirigeant |
2 391
-23.3%
12,7430 464 USD |
2 391 -23.3% | 12,74 | 30 464 USD | |
| 2022-02-14 | 2022-02-11 | V Vente |
Chief Scientific Officer Dirigeant |
2 498
-22.9%
12,7431 827 USD |
2 498 -22.9% | 12,74 | 31 827 USD | |
| 2022-02-14 | 2022-02-11 | V Vente |
Chief Operating Officer Dirigeant |
3 735
-2.6%
12,7447 587 USD |
3 735 -2.6% | 12,74 | 47 587 USD | |
| 2022-02-11 | 2022-02-10 | VP Vente planifiée |
Chief Scientific Officer Dirigeant |
2 500
-37.9%
13,3133 275 USD |
2 500 -37.9% | 13,31 | 33 275 USD | |
| 2022-01-05 | 2022-01-03 | VP Vente planifiée |
Versant Venture Capital VII, L.P. Actionnaire important |
92 000
-14.3%
16,001 472 018 USD |
92 000 -14.3% | 16,00 | 1 472 018 USD | |
| 2022-01-05 | 2022-01-03 | VP Vente planifiée |
Versant Venture Capital VII, L.P. Actionnaire important |
308 000
-14.2%
16,004 928 062 USD |
308 000 -14.2% | 16,00 | 4 928 062 USD | |
| 2022-01-05 | 2022-01-03 | VP Vente planifiée |
Versant Venture Capital VII, L.P. Actionnaire important |
600 000
-14.2%
16,009 600 120 USD |
600 000 -14.2% | 16,00 | 9 600 120 USD | |
| 2022-01-05 | 2022-01-03 | VP Vente planifiée | Administrateur non-exécutif Actionnaire important |
92 000
-14.3%
16,001 472 018 USD |
92 000 -14.3% | 16,00 | 1 472 018 USD | |
| 2022-01-05 | 2022-01-03 | VP Vente planifiée | Administrateur non-exécutif Actionnaire important |
308 000
-14.2%
16,004 928 062 USD |
308 000 -14.2% | 16,00 | 4 928 062 USD | |
| 2022-01-05 | 2022-01-03 | VP Vente planifiée | Administrateur non-exécutif Actionnaire important |
600 000
-14.2%
16,009 600 120 USD |
600 000 -14.2% | 16,00 | 9 600 120 USD | |
| 2021-11-17 | 2021-11-15 | A Achat | Administrateur non-exécutif |
1 215 000
+36.0%
14,0017 010 000 USD |
1 215 000 +36.0% | 14,00 | 17 010 000 USD | |
| 2021-11-12 | 2021-11-10 | VP Vente planifiée |
Chief Operating Officer Dirigeant |
6 230
-4.4%
15,4896 440 USD |
6 230 -4.4% | 15,48 | 96 440 USD | |
| 2021-11-12 | 2021-11-09 | VP Vente planifiée |
Chief Scientific Officer Dirigeant |
5 000
-55.0%
13,5367 660 USD |
5 000 -55.0% | 13,53 | 67 660 USD | |
| 2021-11-09 | 2021-11-08 | VP Vente planifiée |
Chief Operating Officer Dirigeant |
13 770
-8.9%
15,17208 938 USD |
13 770 -8.9% | 15,17 | 208 938 USD | |
| 2021-11-09 | 2021-11-05 | VP Vente planifiée |
Chief Operating Officer Dirigeant |
5 000
-3.1%
14,0070 000 USD |
5 000 -3.1% | 14,00 | 70 000 USD | |
| 2021-11-09 | 2021-11-05 | VP Vente planifiée |
Chief Operating Officer Dirigeant |
15 000
-8.6%
14,00210 000 USD |
15 000 -8.6% | 14,00 | 210 000 USD | |
| 2021-06-17 | 2021-06-16 | VP Vente planifiée |
Chief Medical Officer Dirigeant |
20 000
-100.0%
16,35326 968 USD |
20 000 -100.0% | 16,35 | 326 968 USD | |
| 2021-05-18 | 2021-05-14 | A Achat |
President, CEO Administrateur exécutif |
1 000
+1.3%
14,4414 440 USD |
1 000 +1.3% | 14,44 | 14 440 USD | |
| 2020-12-10 | 2020-12-09 | A Achat |
President, CEO Administrateur exécutif |
2 000
+3.6%
13,0826 150 USD |
2 000 +3.6% | 13,08 | 26 150 USD | |
| 2020-12-10 | 2020-12-08 | A Achat |
President, CEO Administrateur exécutif |
2 000
+3.8%
13,2426 483 USD |
2 000 +3.8% | 13,24 | 26 483 USD | |
| 2020-11-23 | 2020-11-23 | A Achat |
President, CEO Administrateur exécutif |
929
+1.8%
13,6712 699 USD |
929 +1.8% | 13,67 | 12 699 USD | |
| 2020-11-23 | 2020-11-20 | A Achat |
President, CEO Administrateur exécutif |
571
+1.1%
13,697 817 USD |
571 +1.1% | 13,69 | 7 817 USD | |
| 2020-11-23 | 2020-11-19 | A Achat |
President, CEO Administrateur exécutif |
500
+1.0%
13,506 750 USD |
500 +1.0% | 13,50 | 6 750 USD | |
| 2020-11-13 | 2020-11-11 | A Achat |
President, CEO Administrateur exécutif |
2 500
+5.2%
13,7534 375 USD |
2 500 +5.2% | 13,75 | 34 375 USD | |
| 2020-11-13 | 2020-11-10 | A Achat |
President, CEO Administrateur exécutif |
2 000
+4.3%
13,8627 720 USD |
2 000 +4.3% | 13,86 | 27 720 USD | |
| 2020-09-17 | 2020-09-15 | V Vente |
SVP, GC and Secretary Dirigeant |
2 396
-5.8%
2,395 731 USD |
2 396 -5.8% | 2,39 | 5 731 USD | |
| 2020-09-17 | 2020-09-15 | V Vente |
Chief Legal Officer Dirigeant |
12 369
-9.2%
2,3929 585 USD |
12 369 -9.2% | 2,39 | 29 585 USD | |
| 2020-09-17 | 2020-09-15 | V Vente |
President and CEO Administrateur exécutif |
32 481
-10.4%
2,3977 691 USD |
32 481 -10.4% | 2,39 | 77 691 USD | |
| 2020-08-11 | 2020-08-07 | V Vente |
Chief Medical Officer Dirigeant |
3 538
-29.5%
2,559 036 USD |
3 538 -29.5% | 2,55 | 9 036 USD | |
| 2020-08-11 | 2020-08-07 | V Vente |
SVP, GC and Secretary Dirigeant |
7 951
-16.2%
2,5520 308 USD |
7 951 -16.2% | 2,55 | 20 308 USD | |
| 2020-08-11 | 2020-08-07 | V Vente |
Chief Legal Officer Dirigeant |
7 951
-5.6%
2,5520 308 USD |
7 951 -5.6% | 2,55 | 20 308 USD | |
| 2020-02-26 | 2020-02-25 | V Vente |
Chief Scientific Officer Dirigeant |
6 823
-1.5%
3,5123 954 USD |
6 823 -1.5% | 3,51 | 23 954 USD | |
| 2020-01-06 | 2020-01-03 | V Vente |
Chief Scientific Officer |
73 311
-14.1%
1,1987 108 USD |
73 311 -14.1% | 1,19 | 87 108 USD | |
| 2019-12-16 | 2019-12-12 | V Vente |
Ferber Celeste SVP, GC and Secretary Dirigeant |
408
-1.5%
1,16475 USD |
408 -1.5% | 1,16 | 475 USD | |
| 2019-12-16 | 2019-12-12 | V Vente |
van Elsas Andrea Chief Scientific Officer Dirigeant |
2 192
-0.4%
1,162 550 USD |
2 192 -0.4% | 1,16 | 2 550 USD | |
| 2019-12-16 | 2019-12-12 | V Vente |
ISAACS STEPHEN T President and CEO Administrateur exécutif |
5 897
-2.0%
1,166 860 USD |
5 897 -2.0% | 1,16 | 6 860 USD | |
| 2019-12-16 | 2019-12-12 | VP Vente planifiée |
Templeman Blaine Chief Legal Officer Dirigeant |
1 264
-1.1%
1,161 470 USD |
1 264 -1.1% | 1,16 | 1 470 USD | |
| 2019-09-17 | 2019-09-13 | V Vente |
Chief Scientific Officer |
634
-0.1%
1,31828 USD |
634 -0.1% | 1,31 | 828 USD | |
| 2019-09-17 | 2019-09-13 | V Vente |
Chief Scientific Officer |
17 959
-3.3%
1,3123 451 USD |
17 959 -3.3% | 1,31 | 23 451 USD | |
| 2019-09-17 | 2019-09-13 | V Vente |
SVP, GC and Secretary |
1 102
-3.9%
1,311 439 USD |
1 102 -3.9% | 1,31 | 1 439 USD | |
| 2019-09-17 | 2019-09-13 | V Vente |
SVP, GC and Secretary |
1 392
-4.7%
1,311 818 USD |
1 392 -4.7% | 1,31 | 1 818 USD |